Continuous infusion of lorazepam versus midazolam in patients in the intensive care unit: Sedation with lorazepam is easier to manage and is more cost-effective

Critical Care Medicine

Volumn 27, Issue 8, 1999, Pages 1461-1465

  Swart, Eleonora L ^a   Strack Van Schijndel, Robert J M ^a   Van Loenen, Arie C ^a   Thijs, Lambertus G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Administration and dosage; Benzodiazepines; Lorazepam; Mechanical ventilation; Midazolam; Pharmacoeconomics; Pharmacokinetics; Sedation

Indexed keywords

LORAZEPAM; MIDAZOLAM;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION;

ADULT; AGED; CONSCIOUS SEDATION; COST SAVINGS; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; DRUG COSTS; DRUG MONITORING; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; LORAZEPAM; MALE; MIDAZOLAM; MIDDLE AGED; NEUROLOGIC EXAMINATION; RESPIRATION, ARTIFICIAL; THERAPEUTIC EQUIVALENCY; TIME FACTORS;

EID: 0032868596     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199908000-00009     Document Type: Article

References (20)

1. 1. Burns AM, Shelly MP, Park GR: The use of sedative agents in critically ill patients. Drugs 1992; 43:507-515
2. 2. Aitkenhead AR: Analgesia and sedation in intensive care. Br J Anaesth 1989; 63: 196-206
3. 3. Kanto J, Klotz U: Intravenous benzodiazepines as anaesthetic agents: Pharmacokinetics and clinical consequences. Acta Anaesthesiol Scand 1982; 26:554-569
4. 4. Malacrida R, Fritz ME, Suter PM, et al: Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med 1991; 20: 1123-1126
5. 5. Vinik HR, Kissin I: Sedation in the ICU. Intensive Care Med 1991; 17:S20-S23
6. 6. Amrein R, Hetzel W: Pharmacology of drugs frequently used in ICU's: Midazolam and flumazenil. Intensive Care Med 1991; 17:S1-S10
7. 7. Park GR: Molecular mechanisms of drug metabolism in the critically ill. Br J Anaesth 1996; 77:32-49
8. 8. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
9. 9. O'Sullivan G, Park GR: The assessment of sedation. J Clin Intensive Care 1990; 1:116-121
10. 10. Lovstad RZ, Bredesen JE, Aasmundstad TA, et al: Morphine and midazolam levels in plasma during sedation of critically ill patients. Clin Int Care 1996; 7:282-290
11. 11. Ramsay MAE, Savege TM, Simpson BJ, et al: Controlled sedation woth alphaxolone/ alphadone. BMJ 1974; 2:656-659
12. 12. Swart EL, Mooren RAG, Van Loenen AC: Compatibility of lorazepam and midazolam hydrochloride with selected drugs during simulated Y-site administration. Am J Health Syst Pharm 1995; 52:2020-2025
13. 13. Vletter AA, Burm AGL, Breimer LTM, et al: High performance liquid Chromatographic assay of midazolam and flumazenil simultaneously in human plasma. J Chromatogr Biomed Appl 1990; 530:177-185
14. 14. Proost JH, Meijer DKF: MW/PHARM, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput Biol Med 1992; 22: 155-163
15. 15. Dundee JW, Johnston HM, Gray RC: Lorazepam as a sedative-amnestic in an intensive care unit. Curr Med Res Opin 1976; 4:290-295
16. 16. Camu F: Clinical use of lorazepam in post-operative intensive care. Acta Anaesthesiol Belg 1978; 29:191-200
17. 17. Krosner SM, Lin HM, Nagy K, et al: Efficacy and cost: Comparison of lorazepam and midazolam for continuous iv sedation in critically injured trauma patients. Crit Care Med 1994; 22:A54
18. 18. Pohlman AS, Simpson KP, Hall JB: Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: A prospective, randomized study. Crit Care Med 1994; 22: 1241-1247
19. 19. Persson MP, Nilsson A, Hartvig P: Relation of sedation and amnesia to plasma concentrations of midazolam in surgical patients. Clin Pharmacol Ther 1988; 43:324-331
20. 20. Oldenhof H, de Jong M, Steenhoek A, et al: Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability? Clin Pharmacol Ther 1988; 43: 263-269